ACTO Appoints Former J&J President Lori Tierney to Board
ACTO Technologies, Inc. has announced the appointment of Lori Tierney to its Board of Directors, as stated in a press release. Tierney, who previously served as President of Johnson & Johnson Vision, brings over 20 years of experience in the life sciences industry.
Tierney's extensive background includes leadership roles at J&J MedTech, Mentor Aesthetics Specialty Surgery, AstraZeneca, Endo Pharmaceuticals, and Centocor. Her expertise in commercial operations and customer-centric innovation is expected to support ACTO's mission of pioneering an AI-first future in the life sciences sector.
ACTO's Intelligent Field Excellence platform aims to empower life sciences companies by providing AI-driven tools for field professionals, enhancing their engagement with healthcare providers. The platform also offers real-time insights for senior leaders to improve commercial execution.
Parth Khanna, CEO of ACTO, expressed enthusiasm about Tierney's appointment, highlighting her industry experience and vision as instrumental in advancing the company's AI initiatives.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
TileDB Rebrands as Tile.ai and Names George Llado CEO
Voxel Appoints Three Executives to Lead Revenue and AI Operations
Onos Health Raises $17 Million for Behavioral Health AI Platform
Trifecta Technologies Adds Claude Services Through Anthropic Partnership
Konko AI Raises $6 Million for Patient Journey Platform
Daily AI Brief: the AI news that matters, in your inbox.